Contextual Considerations and Recommendations for Estimating the Value of Alzheimer’s Disease Therapies
Sign Up to like & getrecommendations! Published in 2021 at "PharmacoEconomics"
DOI: 10.1007/s40273-021-01079-6
Abstract: The pipeline for new treatments for Alzheimer’s disease (AD) in the USA contains over 100 different agents, 80% of which can be categorized as disease-modifying therapies. The regulatory approval of the disease-modifying agent aducanumab has… read more here.
Keywords: alzheimer disease; contextual considerations; recommendations estimating; value ... See more keywords
SGLT2 inhibitors: practical considerations and recommendations for cardiologists.
Sign Up to like & getrecommendations! Published in 2018 at "Current Opinion in Cardiology"
DOI: 10.1097/hco.0000000000000561
Abstract: PURPOSE OF REVIEW To address common concerns regarding sodium-glucose cotransporter 2 (SGLT2) inhibitor use for patients with type 2 diabetes mellitus (T2DM) in cardiovascular practice. RECENT FINDINGS SGLT2 inhibitors provide glycemic control and improve cardiovascular… read more here.
Keywords: sglt2 inhibitors; sglt2; practical considerations; glycemic control ... See more keywords